Wuhan Recogen Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Wuhan Recogen Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine (NCT05366296) | Wuhan Recogen Biotechnology Co., Ltd. | 2022-07-01 |
Track Wuhan Recogen Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.